Small,
Journal Year:
2022,
Volume and Issue:
18(15)
Published: March 1, 2022
Abstract
Cuprous‐based
nanozymes
have
demonstrated
great
potential
for
cascade
chemodynamic
therapy
(CDT)
due
to
their
higher
catalytic
efficiency
and
simple
reaction
conditions.
Here,
hollow
cuprous
oxide@nitrogen‐doped
carbon
(HCONC)
dual‐shell
structures
are
designed
as
CDT
oncotherapy.
This
HCONC
with
a
size
distribution
of
130
nm
is
synthesized
by
one‐step
hydrothermal
method
using
cupric
nitrate
dimethyl
formamide
precursors.
The
thin‐layer
(1.88
nm)
enhances
the
water‐stability
reduces
systemic
toxicity
oxide
nanocrystals.
dissolved
Cu
+
in
acid
solution
induces
Fenton‐like
exhibits
fast
rate
catalyzing
H
2
O
into
highly
toxic
hydroxyl
radicals
(·OH).
Meanwhile,
formed
consumes
oversaturated
glutathione
(GSH)
avoid
its
destruction
ROS
at
intracellular
level.
In
general,
both
cellular
animal
experiments
show
that
demonstrates
excellent
antitumor
ability
without
causing
significant
toxicity,
which
may
present
tremendous
clinical
cancer
therapy.
Theranostics,
Journal Year:
2023,
Volume and Issue:
13(2), P. 736 - 766
Published: Jan. 1, 2023
Cellular
mitophagy
means
that
cells
selectively
wrap
and
degrade
damaged
mitochondria
through
an
autophagy
mechanism,
thus
maintaining
intracellular
homeostasis.In
recent
years,
has
received
increasing
attention
as
a
research
hotspot
related
to
the
pathogenesis
of
clinical
diseases,
such
neurodegenerative
cardiovascular
cancer,
metabolic
so
on.It
been
found
regulation
may
become
new
direction
for
treatment
some
diseases.In
addition,
numerous
small
molecule
modulators
have
also
reported,
which
provides
opportunities
comprehend
procedure
potential
therapeutic
development.Taken
together,
in
this
review,
we
summarize
current
understanding
mechanism
mitophagy,
discuss
roles
its
relationship
with
introduce
existing
small-molecule
pharmacological
further
highlight
significance
their
development.
Chemical Reviews,
Journal Year:
2024,
Volume and Issue:
124(5), P. 2699 - 2804
Published: Feb. 29, 2024
The
ability
to
gain
spatiotemporal
information,
and
in
some
cases
achieve
control,
the
context
of
drug
delivery
makes
theranostic
fluorescent
probes
an
attractive
intensely
investigated
research
topic.
This
interest
is
reflected
steep
rise
publications
on
topic
that
have
appeared
over
past
decade.
Theranostic
probes,
their
various
incarnations,
generally
comprise
a
fluorophore
linked
masked
drug,
which
released
as
result
certain
stimuli,
with
both
intrinsic
extrinsic
stimuli
being
reported.
release
then
signaled
by
emergence
signal.
Importantly,
use
appropriate
fluorophores
has
enabled
not
only
this
emerging
fluorescence
marker
for
but
also
provided
modalities
useful
photodynamic,
photothermal,
sonodynamic
therapeutic
applications.
In
review
we
highlight
recent
work
particular
focus
are
activated
tumor
microenvironments.
We
summarize
efforts
develop
other
applications,
such
neurodegenerative
diseases
antibacterials.
celebrates
diversity
designs
reported
date,
from
discrete
small-molecule
systems
nanomaterials.
Our
aim
provide
insights
into
potential
clinical
impact
still-emerging
direction.
Journal of Hematology & Oncology,
Journal Year:
2022,
Volume and Issue:
15(1)
Published: July 18, 2022
Drug
resistance
represents
a
major
obstacle
in
cancer
management,
and
the
mechanisms
underlying
stress
adaptation
of
cells
response
to
therapy-induced
hostile
environment
are
largely
unknown.
As
central
organelle
for
cellular
energy
supply,
mitochondria
can
rapidly
undergo
dynamic
changes
integrate
signaling
pathways
provide
bioenergetic
biosynthetic
flexibility
cells,
which
contributes
multiple
aspects
tumor
characteristics,
including
drug
resistance.
Therefore,
targeting
therapy
overcoming
has
attracted
increasing
attention
various
types
cancer.
Multiple
mitochondrial
processes,
dynamics,
metabolism,
apoptotic
regulatory
machinery,
have
been
demonstrated
be
potential
targets.
However,
recent
insights
into
revealed
complexity
structure
functions,
elusive
functions
biology,
inaccessibility
mitochondria,
posed
challenges
clinical
application
mitochondrial-based
therapeutic
strategies.
discovery
both
novel
mitochondria-targeting
agents
innovative
approaches
is
urgently
required.
Here,
we
review
most
literature
summarize
molecular
their
intricate
connection
with
In
addition,
an
overview
emerging
strategies
target
effectively
chemoresistance
highlighted,
emphasis
on
repositioning
delivery
approaches,
may
accelerate
compounds
therapy.
Journal of the American Chemical Society,
Journal Year:
2022,
Volume and Issue:
144(10), P. 4667 - 4677
Published: March 7, 2022
Constructing
artificial
dynamic
architectures
inside
cells
to
rationally
interfere
with
organelles
is
emerging
as
an
efficient
strategy
regulate
the
behaviors
and
fate
of
cells,
thus
providing
new
routes
for
therapeutics.
Herein,
we
develop
intracellular
K+-mediating
assembly
DNA
tetrahedrons
which
realizes
mitochondrial
interference
consequent
regulation
on
energy
metabolism
living
cells.
In
designer
tetrahedron,
one
vertex
was
modified
triphenylphosphine
(TPP)
targeting,
other
three
vertexes
were
tethered
guanine-rich
sequences
that
could
realize
formation
intermolecular
G-quadruplexes,
consequently
led
form
aggregates
in
cytoplasm.
The
specially
targeted
mitochondria
served
a
polyanionic
barrier
substance
communication,
generating
significant
inhibition
effect
aerobic
respiration
function
associated
glycolysis
process,
reduced
production
adenosine
triphosphate
(ATP).
lack
ATP
impeded
lamellipodium
essential
movement
resulting
inhibitory
cell
migration.
Remarkably,
migration
capacity
suppressed
by
high
50%
cancer
This
work
provides
manipulation
via
endogenous
molecule-mediating
exogenous
envisioned
have
great
potential
precise
biomedicine.
Exploration,
Journal Year:
2023,
Volume and Issue:
3(2)
Published: April 1, 2023
Abstract
Functional
subcellular
organelle
mitochondria
are
emerging
as
a
crucial
player
and
driver
of
cancer.
For
maintaining
the
sites
cellular
respiration,
experience
production,
accumulation
reactive
oxygen
species
(ROS)
underlying
oxidative
damage
in
electron
transport
chain
carriers.
Precision
medicine
targeting
can
change
nutrient
availability
redox
homeostasis
cancer
cells,
which
might
represent
promising
strategy
for
suppressing
tumor
growth.
Herein,
this
review
highlights
how
modification
capable
manipulating
nanomaterials
ROS
generation
strategies
influence
or
compensate
state
mitochondrial
homeostasis.
We
propose
foresight
to
guide
research
innovation
with
an
overview
seminal
work
discuss
future
challenges
our
perspective
on
commercialization
novel
mitochondria‐targeting
agents.
Signal Transduction and Targeted Therapy,
Journal Year:
2022,
Volume and Issue:
7(1)
Published: Nov. 19, 2022
Abstract
Cancer
is
a
major
threat
to
human
health.
Among
various
treatment
methods,
precision
therapy
has
received
significant
attention
since
the
inception,
due
its
ability
efficiently
inhibit
tumor
growth,
while
curtailing
common
shortcomings
from
conventional
cancer
treatment,
leading
towards
enhanced
survival
rates.
Particularly,
organelle-targeted
strategies
enable
precise
accumulation
of
therapeutic
agents
in
organelles,
locally
triggering
organelle-mediated
cell
death
signals
which
can
greatly
reduce
threshold
dosage
and
minimize
side-effects.
In
this
review,
we
comprehensively
discuss
history
recent
advances
targeted
therapies
on
specifically
including
nucleus,
mitochondria,
lysosomes
endoplasmic
reticulum,
focusing
organelle
structures,
signal
pathways,
design
guidelines
nanomedicines
based
intervention
mechanisms.
Furthermore,
perspective
future
research
clinical
opportunities
potential
challenges
oncology
presented.
Through
demonstrating
developments
therapies,
believe
article
further
stimulate
broader
interests
multidisciplinary
technology
development
for
enabling
advanced
their
corresponding
clinic
translations.
Advanced Functional Materials,
Journal Year:
2022,
Volume and Issue:
32(16)
Published: Jan. 10, 2022
Abstract
Phototheranostic
agents
have
thrived
as
promising
tools
for
cancer
theranostics
because
of
the
integration
sensitive
in
situ
fluorescence
imaging
and
effective
multi‐model
synergistic
therapy.
However,
how
to
manipulate
intangible
photon
energy
transfer
balance
competitive
radiative
nonradiative
processes
is
still
challenging.
Although
numerous
phototheranostic
molecules
are
reported,
their
complicated
molecular
design
tedious
synthesis
often
stumble
further
development.
Herein,
three
simple
with
electron
donating−accepting
structures
developed.
The
acceptor
engineering
on
by
introducing
acridinium
unit
gives
rise
TPEDCAc
aggregation‐induced
second
near‐infrared
emission
(AIE
NIR‐II),
high
reactive
oxygen
species
generation
capability,
excellent
photothermal
conversion
efficiency
(44.8%)
due
drastic
intramolecular
motion
large
rotor
balanced
AIE
effect.
Experimental
analysis
calculation
controlled
suggested
that
torsional
angle
strong
electron‐withdrawing
ability
keys
NIR‐II
photodynamic/photothermal
conversion.
Impressively,
positively
charged
shows
mitochondria‐targeting
capability
performance
vivo
multi‐modal
under
NIR
laser
irradiation.
Hence,
this
work
not
only
provides
a
single
AIE‐based
theranostic
system
but
inspires
new
insights
into
future
development
platforms.
Chemical Science,
Journal Year:
2022,
Volume and Issue:
13(15), P. 4239 - 4269
Published: Jan. 1, 2022
Small-molecule
prodrugs
have
become
the
main
toolbox
to
improve
unfavorable
physicochemical
properties
of
potential
therapeutic
compounds
in
contemporary
anti-cancer
drug
development.
Many
approved
small-molecule
prodrugs,
however,
still
face
key
challenges
their
pharmacokinetic
(PK)
and
pharmacodynamic
(PD)
properties,
thus
severely
restricting
further
clinical
applications.
Self-assembled
emerged
as
they
could
take
advantage
benefits
both
prodrug
design
nanomedicine,
so
maximize
loading,
reduce
premature
leakage,
PK/PD
parameters
targeting
ability.
Notably,
temporally
spatially
controlled
release
drugs
at
cancerous
sites
be
achieved
by
encoding
various
activable
linkers
that
are
sensitive
chemical
or
biological
stimuli
tumor
microenvironment
(TME).
In
this
review,
we
comprehensively
summarized
recent
progress
made
development
single/multiple-stimulus-responsive
self-assembled
for
mono-
combinatorial
therapy.
A
special
focus
was
placed
on
conjugation
strategies
(polymer-drug
conjugates,
drug-drug
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Aug. 10, 2023
Rapid
advancements
in
materials
science
and
nanotechnology,
intertwined
with
oncology,
have
positioned
photothermal
therapy
(PTT)
as
a
promising
noninvasive
treatment
strategy
for
cancer.
The
breast's
superficial
anatomical
location
aesthetic
significance
render
breast
cancer
particularly
pertinent
candidate
the
clinical
application
of
PTT
following
melanoma.
This
review
comprehensively
explores
research
conducted
on
various
types
nanoparticles
employed
elaborates
their
specific
roles
mechanisms
action.
integration
existing
therapies
is
scrutinized,
underscoring
its
potential
synergistic
outcomes.
Additionally,
underlying
consequential
modifications
to
tumor
microenvironment
after
are
elaborated
from
medical
perspective.
Future
directions
suggested,
an
emphasis
development
integrative
platforms
that
combine
multiple
therapeutic
approaches
optimization
nanoparticle
synthesis
enhanced
efficacy.
goal
push
boundaries
toward
comprehensive,
clinically
applicable
Advanced Materials,
Journal Year:
2022,
Volume and Issue:
35(21)
Published: Nov. 29, 2022
Abstract
Emerging
as
a
potent
anticancer
treatment,
subcellular
targeted
cancer
therapy
has
drawn
increasing
attention,
bringing
great
opportunities
for
clinical
application.
Here,
two
targeting
strategies
four
main
organelles
(mitochondria,
lysosome,
endoplasmic
reticulum,
and
nucleus),
including
molecule‐
nanomaterial
(inorganic
nanoparticles,
micelles,
organic
polymers,
others)‐based
delivery
or
therapeutic
strategies,
are
summarized.
Phototherapy,
chemotherapy,
radiotherapy,
immunotherapy,
“all‐in‐one”
combination
among
the
covered
in
detail.
Such
materials
constructed
based
on
specific
properties
relevant
mechanisms
of
organelles,
enabling
elimination
tumors
by
inducing
dysfunction
corresponding
destroying
structures.
The
challenges
faced
organelle‐targeting
therapies
also
Looking
forward,
paradigm
with
enhanced
efficacy
compared
to
current
approaches
is
envisioned.